Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Antibody responses to poliovirus type 3 were studied in fecal samples of 66 children immunized with 3 doses of enhanced-potency inactivated poliovirus vaccine (E-IPV), followed by 1 dose of monovalent oral poliovirus vaccine (OPV, type 3 Sabin). One fecal sample taken before OPV vaccination and 9 collected thereafter were tested for neutralizing antibodies by a microneutralization assay and for class-specific responses by heavy chain-capture radioimmunoassays. Both neutralizing antibody and IgA responses usually occurred during the second week and coincided with ceasing of virus excretion or a decrease in the excreted virus titer. Half of the vaccinees had received a trypsin-modified E-IPV, but their responses did not differ from those of children immunized with the regular E-IPV. These results are in agreement with the view that an intestinal antibody response, mainly consisting of IgA, may be involved in the ceasing of a primary poliovirus excretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunization with live-attenuated vaccine mimics natural infection and results in the induction of a local secretory antibody (IgA) response that is associated with a reduction in shedding of poliovirus from the intestine [3], [4].”
From Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge (2012) · cites this paper as [4]
Citations
Cites
Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., Thoms, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240
Minor, P. D., John, A., Ferguson, M., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-4-693 · Cited by 203 · cited 1×
“Antigenic mutants demonstrated by monoclonal antibodies are known to occur in OPV recipients [23].”
BackgroundFaden, H., Modlin, J. F., Thoms, M. L., McBean, A. M., Ferdon, M. B., & Ogra, P. L. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1291 · Cited by 178
Current status of poliovirus infections
Melnick, J. L. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.293 · Cited by 121 · cited 1×
“The natural course of infection is best known for polioviruses, the causative agents of paralytic poliomyelitis [1].”
BackgroundVaccine-Associated Paralytic Poliomyelitis
Beausoleil, J. L., Nordgren, R. E., & Modlin, J. F. (1994) · Journal of Child Neurology · doi:10.1177/088307389400900324 · Cited by 108
Viral Vaccination Via the Mucosal Routes
Ogra, P. L. O., Fishaut, M., & Gallagher, M. R. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.3.352 · Cited by 106
Pipkin, P. A., Wood, D. J., Racaniello, V. R., & Minor, P. D. (1993) · Journal of Virological Methods · doi:10.1016/0166-0934(93)90022-j · Cited by 105
Modlin, J. F., Halsey, N. A., Thoms, M. L., Meschievitz, C. K., Patriarca, P. A., & the Baltimore Area Polio Vaccine Study Group (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s228 · Cited by 93
Fricks, C. E., Icenogle, J. P., & Hogle, J. M. (1985) · Journal of Virology · doi:10.1128/jvi.54.3.856-859.1985 · Cited by 70 · cited 1×
“treating the immunogen with trypsin that selectively cleaves the BC-loop [15, 16].”
Background
Cited by
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Hird, T. R., & Grassly, N. C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002599 · Cited by 221
Expert Review on Poliovirus Immunity and Transmission
Duintjer Tebbens, R. J., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., Patriarca, P. A., Sutter, R. W., Wright, P. F., et al. (2013) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01864.x · Cited by 109
“Grading Table of the Evidence for Average Time Until the Last Positive Stool Specimen and Proportions with Fecal Excretion Over Time from Monovalent OPV Challenge Studies with at Least Two Stool Specimen Collection Times Number of Included Studies(refs)a from Which We Could Extract Proportion Excreting as Average Time…”
MethodSelf-citationNorton, E. B., Bauer, D. L., Weldon, W. C., Oberste, M. S., Lawson, L. B., & Clements, J. D. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.069 · Cited by 76
Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 85
Waning Intestinal Immunity After Vaccination With Oral Poliovirus Vaccines in India
Grassly, N. C., Jafari, H., Bahl, S., Sethi, R., Deshpande, J. M., Wolff, C., Sutter, R. W., & Aylward, R. B. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis241 · Cited by 72
Mucosal immunity to poliovirus
Connor, R. I., Brickley, E. B., Wieland‐Alter, W., Ackerman, M. E., Weiner, J. A., Modlin, J. F., Bandyopadhyay, A. S., & Wright, P. F. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00428-0 · Cited by 72
Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine
Zhao, T., Li, J., Fu, Y., Ye, H., Liu, X., Li, G., Yang, X., & Yang, J. (2020) · npj Vaccines · doi:10.1038/s41541-020-0194-5 · Cited by 63
Diedrich, S., Claus, H., & Schreier, E. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-2 · Cited by 43
“The production of local secretory IgA antibodies in the gut mucosa may play a major role in protection [14, 15 ].”
BackgroundInnate Host Barriers to Viral Trafficking and Population Diversity
Pfeiffer, J. K. (2010) · Advances in virus research · doi:10.1016/b978-0-12-385034-8.00004-1 · Cited by 51
“For poliovirus, the appearance of poliovirus-specific IgA in the intestine coincides with decline inpoliovirus shedding and eventual clearance (Valtanen et al., 2000).”
BackgroundVieira, J. C., Cooper, P. J., Lovato, R., Mancero, T., Rivera, J., Proaño, R. S., López, A. A. M., Guderian, R. H., & Guzmán, J. R. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-9 · Cited by 37
Swartz, T. A., Green, M. S., Handsher, R., Sofer, D., Cohen‐Dar, M., Shohat, T., Habib, S. A., BARAK, E., Dror, Z., Somekh, E., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.021 · Cited by 33
Buisman, A., Abbink, F., Schepp, R. M., Sonsma, J. A. J., Herremans, T., & Kimman, T. G. (2008) · The Journal of Infectious Diseases · doi:10.1086/527487 · Cited by 33
Samoilovich, E., Roivainen, M., Titov, L. P., & Hovi, T. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10480 · Cited by 30
Self-citationA seroprevalence study of poliovirus antibody in the population of northern Greece
Frantzidou, F., Diza, E., Halkia, D., & Antoniadis, A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00998.x · Cited by 29
Hovi, T., Lindholm, N., Savolainen, C., Stenvik, M., & Burns, C. C. (2004) · Journal of General Virology · doi:10.1099/vir.0.19518-0 · Cited by 30
“We were unable to demonstrate neutralizing antibodies in faecal extracts but this observation cannot be taken as evidence of any deficiency in humoral immunity, as the specimens had been frozen and thawed several times, which is known to expose faecal immunoglobulins to destructive proteases (Hovi et al., 1982; Valtan…”
BackgroundSelf-citationPoliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus
Quarleri, J. F. (2022) · GeroScience · doi:10.1007/s11357-022-00672-7 · Cited by 46
Inactivated poliovirus vaccine and the final stages of poliovirus eradication
Hovi, T. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00515-6 · Cited by 25
Self-citationHuman monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains
Puligedda, R. D., Kouiavskaia, D. V., Adekar, S. P., Sharma, R., Kattala, C. D., Rezapkin, G. V., Bidzhieva, B., Dessain, S. K., & Chumakov, K. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.05.005 · Cited by 23
Taniuchi, M., Begum, S., Uddin, M. J., Platts-Mills, J. A., Liu, J., Kirkpatrick, B. D., Chowdhury, A. H., Jamil, K. M., Haque, R., Petri, W. A., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02406-14 · Cited by 16
Estívariz, C. F., Krow‐Lucal, E., & Mach, O. (2024) · Pathogens · doi:10.3390/pathogens13121128 · Cited by 10
Murphy, B. R. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50047-4 · Cited by 15
Determination of poliovirus-specific IgA in saliva by ELISA tests
Ap, I., Dragunsky, E. M., Ivanova, O. E., Rezapkin, G. V., Potapova, S., & Chumakov, K. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.01.030 · Cited by 8
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5719-0_10 · Cited by 7
“IgA induced in the gut plays an important role in terminating primary infection in the intestinal tract and the tonsils [3, 152] affecting both fecal–oral and oral–oral transmission.”
BackgroundUse of internal standard RNA molecules for the RT-PCR amplification of the faeces-borne RNA viruses
Kim, K., Park, J., Chung, Y., Cheon, D., Lee, I.-B., Lee, S., Yoon, J.-D., Cho, H., Song, C., & Lee, K. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00016-2 · Cited by 7
Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
Zhao, T., Li, J., Shi, H., Ye, H., Ma, R., Fu, Y., Liu, X., Li, G., Yang, X., Zhao, Z., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1911213 · Cited by 7
“, in the intestine, where it induces a local secretory IgA response, thereby reducing the intestinal shedding of poliovirus.(11) To reduce the probability of generating cVDPVs in polio vaccine recipients, enhancing the poliospecific mucosal immunity generated by vaccination is critical.”
BackgroundFriis, H., & Sandström, B. (2001) · Modern nutrition · doi:10.1201/9781420042351.ch8 · Cited by 5
Jehan, F., Nisar, M. I., Lassi, Z. S., Omer, S. B., & Zaidi, A. K. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010857.pub2 · Cited by 4
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0851-3_839 · Cited by 5
Impact of Infection–Nutrient Interactions in Infants, Children, and Adolescents
Orellana, R. A., & Coss‐Bu, J. A. (2014) · CRC Press eBooks · doi:10.1201/b17311-15 · Cited by 3
Jehan, F., Nisar, M. I., Lassi, Z. S., Omer, S. B., & Zaidi, A. K. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010857 · Cited by 3
RetractedInducing Quality Immune Response to Respiratory Viruses May Not Be a Simple Task
Ranga, U., & Asokan, M. (2021) · Current Science · doi:10.18520/cs/v120/i8/1315-1323 · Cited by 1
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 4
An Indian Perspective of Some Recent Developments in Polio, DPT, Zika and Rotavirus Vaccines
Iyer, V. V., Tejal, A., Poddar, A., Maithili, D., Rasika, L. G., Bendre, A., & Jaswal, V. (2017) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000215
“OPV is said to be more effective than IPV as secretory antibodies are not found after immunization with IPV unless the individual is exposed to live polio virus prior to vaccination[10].”
BackgroundShulman, L. M. (2020) · Springer eBooks · doi:10.1007/978-1-4939-2493-6_839-3
Shulman, L. M. (2023) · Encyclopedia of sustainability science and technology series · doi:10.1007/978-1-0716-2463-0_839
Metadata
- Authors
- Valtanen, S., Roivainen, M., Piirainen, L., Stenvik, M., & Hovi, T.
- Corresponding author
- Hovi, Tapani
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07
- Volume
- 182
- Issue
- 1
- Pages
- 1-5
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2115558992
- Cited by
- 36
- References
- 24
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2017: 2 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 6
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- poliovirus type 3, IgA, neutralizing antibodies, oral polio vaccine, inactivated poliovirus vaccine, children, microneutralization
- MeSH terms
- Feces, Humans, Immunoglobulin A, Secretory, Immunoglobulin G, Immunoglobulin M, Infant, Intestines, Poliovirus Vaccine, Inactivated, Poliovirus, Viral Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.